Medical devices, healthcare technology and the business of care
PMA approval · P070008

STRATOS LV CRT-P AND STRATOS LV-T CRT-P, COROX OTW BP LEAD AND COROX OTW-S BP LEAD

Biotronik, Inc. · Decision date May 12, 2008

MEDTECHLEDGER EXPLANATIONP070008

What did the FDA approve?

FDA approved the STRATOS LV CRT-P and STRATOS LV-T CRT-P with 702.U programmer software for the ICS 3000, along with the COROX OTW BP and COROX OTW-S BP leads. The pulse generators are indicated for patients with moderate to severe heart failure (NYHA Class III/IV), left ventricular dysfunction (EF < 35%), and QRS > 120 ms who remain symptomatic despite stable, optimal heart failure drug therapy.

The COROX OTW BP and COROX OTW-S BP are bipolar steroid-eluting left ventricular pacing leads intended for permanent implantation in the left ventricle via the coronary veins. They provide pacing and/or sensing when used with a compatible IS-1 pulse generator. The statement reports the approved indication and intended use; it does not independently establish safety or clinical effectiveness.

FDA approval order statement

APPROVAL FOR THE STRATOS LV CRT-P AND STRATOS LV-T CRT-P WITH 702.U PROGRAMMER SOFTWARE FOR THE ICS 3000 AND COROX OTW BP LEAD AND COROX OTW-S BP LEAD. THE STRATOS LV CRT-P AND THE STRATOS LV-T CRT-P ARE INDICATED FOR PATIENTS WHO HAVE MODERATE TO SEVERE HEART FAILURE (NYHA CLASS II1/IV), INCLUDING LEFT VENTRICULAR DYSFUNCTION (EF< 35%) AND QRS > 120 MS AND REMAIN SYMPTOMATIC DESPITE STABLE, OPTIMAL HEART FAILURE DRUG THERAPY. THE COROX OTW BP AND COROX OTW-S BP LEFT VENTRICULAR PACING LEADS ARE BIPOLAR STEROID-ELUTING LEADS, INTENDED FOR PERMANENT IMPLANTATION IN THE LEFT VENTRICLE VIA THE CORONARY VEINS TO PROVIDE PACING AND/OR SENSING WHEN USED IN CONJUNCTION WITH A COMPATIBLE IS-1 PULSE GENERATOR.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
May 12, 2008

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P070008
Regulatory pathway
Premarket approval application
Product code
NKE
Decision code
APPR
Decision date
May 12, 2008
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P).

Product code
NKE
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P070008 received

    Application receipt date recorded by FDA.

  2. P070008 · FDA decision

    APPR

  3. P070008/S172 · Related supplement

    Edora 8 HF-T QP 407137 Edora 8 HF-T 407138 Evity 8 HF-T QP 407139 Evity 8 HF-T 407140 Enitra 8 HF-T QP 407141 Enitra 8 H

  4. P070008/S182 · Related supplement

    Edora 8 HF-T QP Edora 8 HF-T Evity 8 HF-T QP Evity 8 HF-T Enitra 8 HF-T QP Enitra 8 HF-T Enticos 8 HF-T QP Enticos 8 HF-

  5. P070008/S181 · Related supplement

    Edora 8 HF-T QP 407137; Edora 8 HF-T 407138; Evity 8 HF-T QP 407139; Evity 8 HF-T 407140; Enitra 8 HF-T QP 407141; Enitr

  6. P070008/S183 · Related supplement

    Edora 8 HF-T QP, Edora 8 HF-T, Evity 8 HF-T QP, Evity 8 HF-T, Enitra 8 HF-T QP, Enitra 8 HF-T

  7. P070008/S184 · Related supplement

    Sentus ProMRI OTW QP S-75, Sentus ProMRI OTW QP S-85, Sentus ProMRI OTW QP S-95, Sentus ProMRI OTW QP L-75, Sentus ProMR

Timeline entries are records held by MedtechLedger for P070008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070008

Explore the linked device profile

Other records with product code NKE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records